NATIONAL HEALTH SERVICE, SCOTLAND Citation and commencement 1 1 These Regulations may be cited as the National Health Service (General Medical Services) (Scotland) Amendment (No.3) Regulations 1999 and shall come into force on 1st July 1999. 2 In these Regulations, “the principal Regulations ” means the National Health Service (General Medical Services) (Scotland) Regulations 1995 . Amendment to Schedule 1 to the principal Regulations 2 In Schedule 1 to the principal Regulations (terms of service for doctors), after paragraph 29A there is inserted– 29B 1 Before supplying the drugs or appliances recorded on a prescription form in accordance with paragraph 29(2)(a) or providing the listed drugs or medicines or listed appliances ordered on a prescription form signed by a nurse prescriber in accordance with paragraph 29A(2) a doctor who is required by the Board under regulation 34 to provide drugs or appliances to a patient shall request any person who makes a declaration on the prescription form claiming either charge exemption under regulation 7 of the National Health Service (Charges for Drugs and Appliances) (Scotland) Regulations 1989 (“the 1989 Regulations ”) or charge remission under the National Health Service (Travelling Expenses and Remission of Charges) (Scotland) Regulations 1988 . 2 Sub-paragraph (1) shall not apply in respect of claims for exemption under regulation 7(1)(a) to (f) of the 1989 Regulations where the dispensing doctor has information in his possession at the time of supplying the item which confirms that the patient is entitled to the exemption claimed. 3 Where the person presenting the prescription form does not show valid evidence of entitlement and the dispensing doctor, in respect of a claim for exemption made under regulation 7(1)(a) to (f) of the 1989 Regulations does not have evidence in his possession to confirm that the patient is entitled to make that claim, the dispensing doctor shall mark the patient’s prescription form accordingly before supplying the prescribed item. . Amendment to Schedule 11 to the principal Regulations 3 In Schedule 11 to the principal Regulations (drugs to be supplied by general medical practitioners or prescribed for supply under pharmaceutical services only in certain circumstances) after the entry relating to Nizoral Cream there is inserted in columns 1, 2 and 3 respectively the following– The following drugs for the treatment of erectile dysfunction– Alprostadil (Caverject), (MUSE), (Viridal) Moxisylyte Hydrochloride (Erecnos) Thymoxamine Hydrochloride (Erecnos) Sildenafil (Viagra) a A man with erectile dysfunction who on 14th September 1998 was receiving treatment under the Act for this condition with any of the following drugs– Alprostadil (Caverject), (MUSE), (Viridal) Moxisylyte Hydrochloride (Erecnos) Thymoxamine Hydrochloride (Erecnos) Sildenafil (Viagra); or b a man who is suffering from any of the following– diabetes multiple sclerosis Parkinson’s disease poliomyelitis prostate cancer severe pelvic injury single gene neurological disease spina bifida spinal cord injury; or c a man who is receiving treatment for renal failure by dialysis; or d a man who has had the following surgery– prostatectomy radical pelvic surgery renal failure treated by transplant Treatment of erectile dysfunction Sewel Parliamentary Under Secretary of State, Scottish Office St Andrew’s House, Edinburgh 8th June 1999